SCHEMBL18975001

SCHEMBL18975001

COc1ccc2[nH]cc(C(=O)OCC34CCN(CC3)C4)c2c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17417820 0.94 — —
Hydrochloric Acid SCHEMBL17417756 0.93 — —
SCHEMBL18975234 0.89 — —
SCHEMBL18975513 0.89 — —
SCHEMBL18975146 0.89 — —
SCHEMBL18975186 0.87 — —
SCHEMBL18974976 0.84 KCNH2 (0.67) —
SCHEMBL17417818 0.83 — —
SCHEMBL17417596 0.83 — —
Hydrochloric Acid SCHEMBL17417719 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170166561-A1 QUINUCLIDINE COMPOUNDS FOR MODULATING ALPHA7-NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY ALPHARMAGEN LLC (US) 2017-06-15 — — US disclosed
Send feedback